Stem Point Capital LP Geron Corp Transaction History
Stem Point Capital LP
- $312 Billion
- Q2 2025
A detailed history of Stem Point Capital LP transactions in Geron Corp stock. As of the latest transaction made, Stem Point Capital LP holds 6,649,244 shares of GERN stock, worth $8.98 Million. This represents 3.01% of its overall portfolio holdings.
Number of Shares
6,649,244
Previous 960,307
592.41%
Holding current value
$8.98 Million
Previous $1.53 Billion
514.02%
% of portfolio
3.01%
Previous 0.49%
Shares
2 transactions
Others Institutions Holding GERN
# of Institutions
281Shares Held
509MCall Options Held
884KPut Options Held
564K-
Ra Capital Management, L.P. Boston, MA60.4MShares$81.5 Million1.86% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$62.8 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT43MShares$58.1 Million2.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA35.6MShares$48.1 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$36.8 Million8.13% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $510M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...